CF Industries Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CF research report →
Range $110 – $162
Price Chart
About the company
CF Industries Holdings, Inc. is a global producer and distributor of hydrogen and nitrogen-based products. These essential chemicals serve a variety of purposes worldwide, including energy generation, agricultural fertilization, environmental emissions reduction, and numerous other industrial applications.
- CEO
- Christopher D. Bohn
- IPO
- 2005
- Employees
- 2,900
- HQ
- Northbrook, IL, US
Get TickerSpark's AI analysis on CF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.90B
- P/E
- 8.00
- Fwd P/E
- 7.76
- PEG
- 0.11
- P/S
- 2.09
- P/B
- 3.00
- EV/EBITDA
- 4.01
- Div Yield
- 1.93%
- Gross Margin
- 42.57%
- Op Margin
- 38.68%
- Net Margin
- 27.48%
- ROE
- 40.30%
- ROIC
- 16.79%
Latest fiscal year · YoY change
- Revenue
- $7.08B+19.3%
- Gross Profit
- $2.72B+32.5%
- Op Income
- $2.37B
- Net Income
- $1.46B+19.5%
- EPS
- $8.98+33.0%
- OCF Growth
- +21.2%
- FCF Growth
- +2.8%
- 52W High
- $141.96
- 52W Low
- $75.42
- 50D MA
- $119.91
- 200D MA
- $118.32
- Beta
- 0.40
- RSI (14)
- 46
- Avg Volume
- 2.44M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CF Industries posted strong first-nine-month 2026 results, with EBITDA above its mid-cycle estimate and management signaling a constructive nitrogen market and continued capital returns.· November 5, 2026
- First nine months adjusted EBITDA was about $3 billion, above CF's $2.9 billion mid-cycle EBITDA estimate.
- Q3 net earnings were $436 million, or $2.87 per diluted share; Q3 adjusted EBITDA was $833 million.
- Operational performance remained strong, with 97% ammonia capacity utilization year to date and a trailing 12-month incident rate of 0.1 per 200,000 hours.
- Management said nitrogen markets stayed constructive, with low inventories, disrupted global supply, and strong fall demand in North America.
- CF continued returning cash and investing in growth, repurchasing $367 million of stock in Q3 and advancing Blue Point One, Yazoo City CCS, and other projects.
For the first nine months of 2026, CF Industries reported net earnings attributable to common stockholders of approximately $1.8 billion, or $11.60 per diluted share. EBITDA and adjusted EBITDA were both approximately $3 billion. For the third quarter, net earnings attributable to common stockholders were $436 million, or $2.87 per diluted share, with EBITDA of $822 million and adjusted EBITDA of $833 million. Trailing 12-month net cash from operations was approximately $3.1 billion and free cash flow was approximately $2 billion. Looking ahead, 2026 consolidated capital expenditures are expected to be approximately $1.3 billion, with CF's share at approximately $950 million. Blue Point One's projected total cost remains $3.7 billion, common facilities remain at $550 million, and ammonia production is expected to commence in 2029. Management did not provide specific next-quarter earnings guidance, but said the global nitrogen supply-demand balance is expected to remain constructive into 2027.
Chris Bohn framed the quarter as validation of CF's low-cost, low-risk North American model, saying the company is outperforming its mid-cycle estimate and generating strong cash flow. He emphasized safety and operating reliability, noting the company's lowest-ever recordable incident rate and 97% ammonia utilization year to date. Strategically, he highlighted growth projects, including Blue Point One, Donaldsonville CCS, Yazoo City CCS, and a FEED study for Courtright DEF, and said these investments plus buybacks are expected to increase nitrogen per share by 15% by 2030. His tone was confident and constructive, with repeated emphasis on long-term shareholder value creation.
Andrew Scribner focused on the financial engine: about $3 billion of EBITDA in the first nine months, roughly $3.1 billion of operating cash flow over the trailing 12 months, and about $2 billion of free cash flow. He said free-cash-flow conversion has averaged about 60% over five years, though the recent period was slightly lower because of $306 million of deposits tied to a historical U.S.-Canada transfer pricing matter from 2012. He also reiterated capex of approximately $1.3 billion in 2026, CF's share at approximately $950 million, and said Blue Point's remaining investment is manageable given strong free cash flow. On capital allocation, he noted $367 million of share repurchases in Q3 and support for opportunistic buybacks because management believes earnings power is not fully reflected in valuation.
Analysts focused on the durability of the nitrogen backdrop, Europe and Middle East supply losses, Chinese export behavior, Brazil demand, and the impact of higher controllable costs. Management said the long-term supply view has not changed, but the timing of European shutdowns may be accelerating by 12-18 months, and Bert Frost estimated roughly 700,000 to 1 million tons per month still missing from the Gulf due to Middle East disruptions. On China, management said exports remain elevated but are shaped by food-security policy and may continue into early next year. On costs, Andrew said the main drivers were higher purchased ammonia for U.K. operations, Yazoo fixed-cost absorption, and some logistics inflation; on Yazoo, management expects a first-half 2027 ramp, with insurance recoveries largely offsetting rebuild spending over time.
The bull case from the call is that CF is executing well in a structurally tighter nitrogen market while generating outsized cash. Management said global inventories are low, supply remains constrained by geopolitics and high energy costs, and deferred demand is now returning, supporting prices into 2027. CF is also expanding its advantage through Blue Point, CCS projects, low-carbon ammonia sales, and a distribution network that management says keeps utilization high and supports superior free cash flow conversion.
The key risks highlighted were timing and volatility: European shutdowns could extend, Middle East supply could recover faster or slower than expected, and Brazil demand is being held back by credit constraints. Management also pointed to higher non-gas costs, especially purchased ammonia and Yazoo rebuild-related fixed costs, as a drag on results. In addition, fertilizer pricing has not fully reflected the tight supply backdrop yet, implying that deferred buying or stronger Chinese exports could delay or blunt upside.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.4%
- Shares Outstanding
- 146.28M
- Float Shares
- 145.44M
of shares held by institutions
1,023 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CF, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Buy | Oct 20, 26 | Filing → |
| Alan ArmstrongSenate | Buy | Mar 27, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jan 9, 26 | Filing → |
| Julia LetlowHouse · LA05 | Buy | Oct 23, 24 | Filing → |
| Julia LetlowHouse · LA05 | Sell | Aug 8, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Sep 5, 25 | Filing → |
| Val HoyleHouse · OR04 | Buy | Oct 29, 24 | Filing → |
| John Peter RickettsSenate · NE | Sell | Sep 21, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 19, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 23, 23 | Filing → |
| Daniel GoldmanHouse · NY10 | Sell | Mar 1, 23 | Filing → |
| Daniel GoldmanHouse · NY10 | Sell | Feb 3, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Sell | Feb 16, 23 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 9, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 19.56M | ▼ 206.74K |
| Blackrock, Inc. | 12.73M | ▼ 297.75K |
| Vanguard Capital Management LLC | 9.91M | ▼ 130.34K |
| State Street Corp | 8.57M | ▲ 42.67K |
| Price T Rowe Associates Inc | 8.47M | ▲ 945.96K |
| Vanguard Portfolio Management LLC | 8.25M | ▼ 278.55K |
| Geode Capital Management, LLC | 4.30M | ▼ 1.09M |
| Capital World Investors | 3.50M | ▲ 182.57K |
| Fmr LLC | 3.27M | ▲ 684.94K |
| Allianz Asset Management Gmbh | 3.11M | ▲ 473.10K |
| Northern Trust Corp | 3.08M | ▼ 24.42K |
| Norges Bank | 3.00M | ▲ 3.00M |
Held by 1,517 ETFs
Biggest fund positions in CF by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 26, 26 | Scribner Andrew | other | 6,464 |
| May 26, 26 | Scribner Andrew | other | 0 |
| Apr 28, 26 | DeHaas Deborah L | other | 1,390 |
| Apr 28, 26 | Wagler Theresa E | other | 1,390 |
| Apr 28, 26 | EAVES JOHN W | other | 1,390 |
| Apr 28, 26 | Ellerbusch Susan A | other | 1,390 |
| Apr 28, 26 | Madrazo Yris Jesus | other | 1,390 |
| Apr 28, 26 | Noonan Anne P | other | 2,208 |
| Apr 28, 26 | TOELLE MICHAEL | other | 1,390 |
| Apr 28, 26 | White Celso L. | other | 1,390 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CF coverage
Recent articles, reports, and earnings notes.

Inside the Phosphate Holdings IPO: Setup, Risks, and Verdict
Phosphate Holdings, Inc. (NASDAQ: PHOS) is expected to list on 2026-08-10, but the price range has not been disclosed. The company has not yet provided shares offered or a market cap. The setup favors a commodity-linked fertilizer story, but shareholders should watch for pricing, float, and whether this is a real new issue or a stale filing reference.

SQM’s quiet rally says the lithium rebound may be more real than skeptics think
SQM’s latest move looks less like a random bounce and more like the market getting ahead of a better lithium tape. Chile’s lithium export value nearly tripling in the first half of 2026 gives that rally a fundamental backbone skeptics have been missing.
Want a deeper read on CF?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Here's Why CF Industries (CF) is a Strong Growth Stock
zacks.com · Nov 19
CF Industries: Capitalizing On Global Disruptions While Building Long-Term Value
seekingalpha.com · Nov 13
Is CF Industries (CF) Stock Undervalued Right Now?
zacks.com · Nov 11
What CF Industries (CF) Said on Its Q3 Earnings Call
marketbeat.com · Nov 7
Morgan Stanley, Chubb and CF Industries: CNBC's ‘Final Trades'
benzinga.com · Nov 6
CF Industries Holdings, Inc. (CF) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
CF Q3 Earnings Miss Estimates as Higher Costs Offset Sales Gains
zacks.com · Nov 5
CF (CF) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.